1. Home
  2. MC vs AXSM Comparison

MC vs AXSM Comparison

Compare MC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moelis & Company

MC

Moelis & Company

HOLD

Current Price

$69.64

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$148.15

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MC
AXSM
Founded
2007
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.9B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
MC
AXSM
Price
$69.64
$148.15
Analyst Decision
Buy
Strong Buy
Analyst Count
9
20
Target Price
$73.50
$176.00
AVG Volume (30 Days)
852.7K
526.6K
Earning Date
10-29-2025
11-03-2025
Dividend Yield
3.73%
N/A
EPS Growth
446.16
N/A
EPS
3.17
N/A
Revenue
$1,467,580,000.00
$561,263,000.00
Revenue This Year
$27.25
$66.20
Revenue Next Year
$17.11
$57.56
P/E Ratio
$22.00
N/A
Revenue Growth
51.19
65.83
52 Week Low
$47.00
$75.56
52 Week High
$82.89
$152.94

Technical Indicators

Market Signals
Indicator
MC
AXSM
Relative Strength Index (RSI) 61.66 56.94
Support Level $62.77 $144.00
Resistance Level $72.26 $150.00
Average True Range (ATR) 2.17 4.15
MACD 0.89 -0.73
Stochastic Oscillator 74.16 57.42

Price Performance

Historical Comparison
MC
AXSM

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: